A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501

Clinical trial NCT04080050 · UNKNOWN

Trial details

NCT number: NCT04080050
Sponsor: REGENXBIO Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Homozygous Familial Hypercholesterolemia (HoFH)

Start date: 2019-09-30
Primary completion: 2024-09-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.